Monopar Therapeutics (MNPR) Non-Current Assets (2016 - 2020)

Monopar Therapeutics' Non-Current Assets history spans 5 years, with the latest figure at $68858.0 for Q3 2020.

  • For Q3 2020, Non-Current Assets changed N/A year-over-year to $68858.0; the TTM value through Sep 2020 reached $386670.0, up 488.26%, while the annual FY2019 figure was $122381.0, 86.18% up from the prior year.
  • Non-Current Assets for Q3 2020 was $68858.0 at Monopar Therapeutics, down from $73050.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $800393.0 in Q4 2016 and bottomed at $65731.0 in Q4 2018.
  • The 5-year median for Non-Current Assets is $122381.0 (2019), against an average of $405876.3.
  • The largest annual shift saw Non-Current Assets tumbled 91.78% in 2018 before it soared 86.18% in 2019.
  • A 5-year view of Non-Current Assets shows it stood at $800393.0 in 2016, then decreased by 0.05% to $800031.0 in 2017, then crashed by 91.78% to $65731.0 in 2018, then skyrocketed by 86.18% to $122381.0 in 2019, then plummeted by 43.73% to $68858.0 in 2020.
  • Per Business Quant, the three most recent readings for MNPR's Non-Current Assets are $68858.0 (Q3 2020), $73050.0 (Q2 2020), and $122381.0 (Q1 2020).